Importance There are limitations in current diagnostic testing approaches for Alzheimer
disease (AD). Objective To examine plasma tau phosphorylated at threonine 217 (P-tau217) as …

Plasma phosphorylated tau181 (P-tau181) might be increased in Alzheimer’s disease (AD),
but its usefulness for differential diagnosis and prognosis is unclear. We studied plasma P-…

Background Plasma tau phosphorylated at threonine 217 (p-tau217) and plasma tau
phosphorylated at threonine 181 (p-tau181) are associated with Alzheimer's disease tau pathology. …

With the potential development of new disease-modifying Alzheimer’s disease (AD) therapies,
simple, widely available screening tests are needed to identify which individuals, who are …

Importance There is an urgent need for inexpensive and minimally invasive blood biomarkers
for Alzheimer disease (AD) that could be used to detect early disease changes. Objective …

Cerebrospinal fluid (CSF) p-tau181 (tau phosphorylated at threonine 181) is an established
biomarker of Alzheimer’s disease (AD), reflecting abnormal tau metabolism in the brain. …

We developed models for individualized risk prediction of cognitive decline in mild cognitive
impairment (MCI) using plasma biomarkers of β-amyloid (Aβ), tau and neurodegeneration. …

Importance Effects of antiamyloid agents, targeting either fibrillar or soluble monomeric
amyloid peptides, on downstream biomarkers in cerebrospinal fluid (CSF) and plasma are …

Introduction The prognostic utility of cerebrospinal fluid (CSF) phosphorylated tau 217 (p‐tau217)
and p‐tau181 is not understood. Methods Analyses included 753 Mayo Clinic Study …

Earthquake instability occurs as a result of strength loss during sliding on a fault. It has been
known for over 50 years that fault compaction or dilatancy may cause significant weakening …